We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+0.26%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$30.7B
AUM Growth
+$988M
(+3.3%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.28%
Top 10 Holdings %
Top 10 Hldgs %
54.65%
Holding
2,179
New
164
Increased
802
Reduced
752
Closed
188
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$124M |
| 2 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$122M |
| 3 |
Alerian MLP ETF
AMLP
|
+$112M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$84.3M |
| 5 |
Schwab International Equity ETF
SCHF
|
+$75.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$92.7M |
| 2 |
TSS
Total System Services, Inc.
TSS
|
+$49.4M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
+$25.4M |
| 4 |
Schwab US REIT ETF
SCHH
|
+$23.4M |
| 5 |
Apple
AAPL
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.77% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 1.86% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIM
701
Chimera Investment
CIM
$1.05B
| $1.12M | ﹤0.01% |
19,060
+1,136
| +6% | +$66.1K |
|
|
PARA
702
DELISTED
Paramount Global Class B
PARA
| $1.12M | ﹤0.01% |
27,678
+5,048
| +22% | +$236K |
|
703
Intellia Therapeutics
NTLA
$1.5B
| $1.11M | ﹤0.01% |
83,513
-610
| -0.7% | -$9.73K |
|
704
SBA Communications
SBAC
$18.4B
| $1.11M | ﹤0.01% |
4,625
+2,413
| +109% | +$597K |
|
705
Aurinia Pharmaceuticals
AUPH
$1.97B
| $1.11M | ﹤0.01% |
208,700
| – | – |
|
706
First Solar
FSLR
$21.8B
| $1.11M | ﹤0.01% |
19,176
-1,677
| -8% | -$107K |
|
|
CLDR
707
DELISTED
Cloudera, Inc.
CLDR
| $1.11M | ﹤0.01% |
125,200
-1,800
| -1% | -$12.5K |
|
708
Erie Indemnity
ERIE
$11.7B
| $1.11M | ﹤0.01% |
5,962
-442
| -7% | -$100K |
|
709
Equifax
EFX
$20.3B
| $1.1M | ﹤0.01% |
7,845
-18
| -0.2% | -$2.54K |
|
710
Capital One
COF
$124B
| $1.1M | ﹤0.01% |
12,125
-680
| -5% | -$61.1K |
|
711
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.7B
| $1.1M | ﹤0.01% |
28,251
+1,315
| +5% | +$51.4K |
|
712
iShares Silver Trust
SLV
$28.1B
| $1.1M | ﹤0.01% |
68,850
-8,083
| -11% | -$129K |
|
713
Trimble
TRMB
$12.3B
| $1.1M | ﹤0.01% |
28,233
+2,173
| +8% | +$87.4K |
|
714
Schwab US TIPS ETF
SCHP
$16.3B
| $1.09M | ﹤0.01% |
38,580
-29,000
| -43% | -$822K |
|
715
Spotify
SPOT
$99.2B
| $1.09M | ﹤0.01% |
9,592
-248
| -3% | -$35K |
|
716
KKR & Co
KKR
$89.2B
| $1.09M | ﹤0.01% |
40,549
-4,947
| -11% | -$130K |
|
717
Centene
CNC
$31.3B
| $1.08M | ﹤0.01% |
25,061
+13,632
| +119% | +$664K |
|
718
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
| $1.08M | ﹤0.01% |
117,739
+585
| +0.5% | +$5.26K |
|
719
Wynn Resorts
WYNN
$10.1B
| $1.08M | ﹤0.01% |
9,934
-2,034
| -17% | -$242K |
|
720
Reaves Utility Income Fund
UTG
$3.69B
| $1.08M | ﹤0.01% |
29,362
+249
| +0.9% | +$9.08K |
|
721
iShares MSCI Japan ETF
EWJ
$21.7B
| $1.07M | ﹤0.01% |
18,935
+3,809
| +25% | +$209K |
|
722
Coca-Cola Europacific Partners
CCEP
$46.5B
| $1.07M | ﹤0.01% |
19,322
+15,693
| +432% | +$877K |
|
723
Carnival Corporation Ltd
CCL
$36.1B
| $1.07M | ﹤0.01% |
24,468
-1,605
| -6% | -$74.1K |
|
|
CGC
724
Canopy Growth
CGC
$375M
| $1.07M | ﹤0.01% |
4,662
-495
| -10% | -$151K |
|
725
Valmont Industries
VMI
$9.44B
| $1.07M | ﹤0.01% |
7,704
+306
| +4% | +$41.1K |
|
Similar funds
Creative Planning's Q3 2019 Portfolio in Review
As of Q3 2019, Creative Planning held 2,179 positions worth $30.7B, up 3.3% from $29.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Creative Planning deployed $1.01B of net new capital in Q3 2019, opening 164 new positions and adding to 802 existing holdings. Its largest new stake was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
By sector, the portfolio is most concentrated in Financials at 4.8% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $92.7M trimmed.
- Creative Planning's largest Q3 2019 buy was Oncternal Therapeutics, Inc. Common Stock: 23,872 shares worth $2.39M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q3 2019, an estimated $124M increase.
- Creative Planning's biggest Q3 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $92.7M.
- Creative Planning fully exited Total System Services, Inc. in Q3 2019, selling an estimated $49.4M.
- Creative Planning's ten largest holdings make up 55% of its $30.7B portfolio in Q3 2019.
- Creative Planning opened 164 new positions and closed 188 in Q3 2019.
- Creative Planning's portfolio value rose 3.3% quarter-over-quarter to $30.7B.
Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.